Contraception and Bariatric Surgery: Evaluation of Contraception and Contraceptive Knowledge of Women Undergoing Bariatric Surgery at the University Hospital of Reims

Bariatric Surgery Candidate Clinical Trial

Official title:

Contraception and Bariatric Surgery: Evaluation of Contraception and Contraceptive Knowledge of Women Undergoing Bariatric Surgery at the University Hospital of Reims

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04219852
• Other study ID #: PO19121*
• Status: Completed
• Start date: September 10, 2019
• Est. completion date: December 31, 2020

Study information

• Verified date: March 2021
• Source: CHU de Reims
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Obesity is a public health phenomenon affecting more than 17% of women in France, and more than 20% of men and women in Champagne-Ardenne.

Obese women are more likely to have an unplanned pregnancy, whereas these pregnancies are more at risk than women of normal weight and should be planned or considered after weight loss. These women are also often less well followed in terms of gynecology and especially on contraception.

More and more patients are opting for bariatric surgery. However, bariatric surgery is not trivial. Indeed, the important loss of weight expected is at risk of nutritional deficiencies. In addition, a large number of patients are still obese during the months following surgery. This is why pregnancy is theoretically contraindicated within 12 or 18 months postoperatively.

Women with bariatric surgery must have been properly informed of these risks so that they can choose a contraceptive method, and that can be adapted to both their risk factors and the surgical technique performed.

Description:

The purpose of this study is to describe contraception in obese women who have undergone bariatric surgery in Champagne-Ardenne.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: December 31, 2020
• Est. primary completion date: April 14, 2020
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years to 50 Years

Eligibility

Inclusion Criteria:

• Women between 18 and 50 years old

• Followed at Reims University Hospital after bariatric surgery

• Pre-menopausal status

• Accepting to participate in the study

Exclusion Criteria:

• Women less than 18 or more than 50 years old

• Women with postmenopausal status

• Women refusing to participate

Related Conditions & MeSH terms

• Bariatric Surgery Candidate

Intervention

Other:
• data collection
data collection

Locations

Country	Name	City	State
France	Chu Reims	Reims

Sponsors (1)

Lead Sponsor	Collaborator
CHU de Reims

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	contraception method	Presence of contraception during the postoperative 3 months consultation	Day 0